Document Detail


Eligibility of patients with peripheral arterial disease for participation in a community-based walking exercise program: a single-centre experience.
MedLine Citation:
PMID:  22990509     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
AIM: Eligibility of patients with peripheral arterial disease (PAD) for exercise therapy is the most important requirement for predicting their training group adherence.
METHODS: In this prospective, exploratory study over a period of 1 year, a total of 462 PAD patients of an angiological outpatient routine care setting were consecutively recruited to the study. As non-eligibility criteria for exercise therapy were defined: resting pain or gangrene (Fontaine stage III and IV PAD), the inability to complete treadmill exercise, or premature treadmill discontinuation due to non-vascular walking pain. Also, PAD patients without subjective walking limitation (Fontaine stage I PAD) were assessed as unwilling, i.e. non-eligible for exercise training adherence. Criterion for patients eligibility was the occurrence of intermittent claudication on treadmill test (Fontaine stage II PAD).
RESULTS: A total of 346 patients (age median 71 years, males 58.5%) were candidates for conservative therapy. Of them, 166 subjects (48%) were assessed as eligible for participation in walking exercise program. 180 of the patients (52%) were deemed as non-eligible to perform walking exercise therapy. 115 patients (33%) were physically limited by critical limb ischemia (Fontaine stage III and IV PAD), severe comorbid cardiovascular disease or orthopaedic disorder. In 65 PAD patients (19%) the subjective walking capacity was not restricted. Social, logistical or other factors were found in 27 patients (8%) to be barriers for exercise training commencement.
CONCLUSION: In half of the PAD patients whose attendance in a community-based walking exercise program would be a therapeutically reasonable activity, a range of vascular and non-vascular factors are obstacles for participation. Further research is needed to investigate what measures might enhance the proportion of exercise therapy participants.
Authors:
U Müller-Bühl; P Engeser; R Leutgeb; J Szecsenyi
Related Documents :
9366319 - Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in st...
6567229 - Exercise and renal function.
9222419 - Different urinary albumin responses to submaximal exercise by normoalbuminuric diabetic...
15867559 - Effects of high-intensity exercises on 13c-nandrolone excretion in trained athletes.
12044019 - Intravaginal surface emg probe design test for urinary incontinence patients.
10023399 - Use of cyproheptadine to control urine spraying and masturbation in a cat.
15833369 - In vivo corticosterone administration at levels occurring with intense exercise does no...
17165639 - Understanding the basics of cardiopulmonary exercise testing.
21794099 - Gastrointestinal complaints in runners are not due to small intestinal bacterial overgr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International angiology : a journal of the International Union of Angiology     Volume:  31     ISSN:  1827-1839     ISO Abbreviation:  Int Angiol     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-09-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8402693     Medline TA:  Int Angiol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  462-7     Citation Subset:  IM    
Affiliation:
Department of General Practice and Health Services Research, University Hospital, Heidelberg, Germany - uwe.mueller-buehl@med.uni-heidelberg.de.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Low frequency of a decreased ankle brachial index and associated conditions in the practice of inter...
Next Document:  Pilot trial of motivational interviewing in patients with peripheral artery disease.